Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

ed Harry P. Erba, MD, Ph.D., University of Michigan, one of the co-principal investigators for this study. "This study helps to define a new approach to treatment for patients unlikely to benefit from conventional 7+3 induction chemotherapy and provides support for the importance of assessing cytogenetics prior to induction treatment."

"The positive results seen in this study provide a compelling case for a novel, effective, therapeutic option for older adult patients with AML who have multiple unfavorable prognostic factors," added Hagop Kantarjian, M.D. MD Anderson Cancer Center and the other co-principal investigator for the CLASSIC II study. "In our published research from MD Anderson, older AML patients with one to three unfavorable prognostic factors are at risk of lower complete remission rates and higher 60-day mortality. We look forward to analyzing the final independently-assessed study results, particularly the remission duration data, for this very difficult-to-treat population."

In addition to presentation at ASCO, a podium appearance of the preliminary CLASSIC-II data also will be delivered by Dr. Erba at the upcoming European Hematology Association meeting in Copenhagen, Denmark on Sunday, June 15.

Study Design

Patients in the CLASSIC-II study must have previously untreated AML, be 60 years or older and be unlikely to benefit from conventional induction chemotherapy based on the presence of at least one of the following adverse prognostic factors: age greater than or equal to 70, pre-existing hematological disorder such as myelodysplastic syndrome (MDS), poor health performance, or intermediate or unfavorable cytogenetics. Patients also had to be previously untreated and unlikely to benefit from conventional induction chemotherapy (7+3 anthracycline plus cytarabine) based on the presence of at least one of these poor prognostic factors at baseline.

Patients received an induction cycle of intravenous clofarabine admin
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 ... having achieved dazzling export-led growth in just 4 ... celebrates its part in winning the Queen,s Award ... awarded to Oxford PharmaGenesis. As part of the ... its clients bring new medicines to the world ...
(Date:4/21/2015)... England , April 21, 2015 ... Queen,s Award for Enterprise, having more than doubled its ... Oxford PharmaGenesis today celebrates winning the Queen,s Award ... local employer is the world,s first HealthScience Communications consultancy, ... in areas of patient need. Having more than doubled ...
(Date:4/21/2015)... 21, 2015 Softheon, Inc., ... and business operation, has confirmed its status as ... of Medicare & Medicaid Services (CMS).  Under this ... access to the Federal Data Hub to assist ... qualified health insurance plans. Through ...
Breaking Medicine Technology:Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Softheon Confirms Web Broker Entity (WBE) Status with the Centers of Medicare & Medicaid Services (CMS) 2
... Primate trials validate efficacy of the processTHOUSAND OAKS, Calif., ... it has successfully completed the initial primate trials validating ... (NELL-1) protein in spinal fusion surgery. 100% fusion ... cystic lesion was observed. The company is currently ...
... experienced mild head trauma or a blast exposure while serving ... with headaches, according to a study released today that will ... Meeting in Seattle, April 25 to May 2, 2009.The study, ... returning from Iraq or Afghanistan in 2008. All had experienced ...
Cached Medicine Technology:Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2For Iraq Veterans, Headaches Continue After Traumatic Brain Injury 2
(Date:4/21/2015)... Approximately 75 million Americans live in areas with ... (EPA). On top of this, consuming alcohol and exposure ... of toxins found in the body. A natural way ... to increase consumption of broccoli. Considered by many as ... – a long-lasting antioxidant – of all cruciferous vegetables. ...
(Date:4/21/2015)... Insuranceautoquote.info has released a new blog post ... . , Collision auto insurance is a policy ... Unlike liability coverage, collision auto insurance also covers the ... benefits to cover the insured’s expenses. , ... provide all the necessary resources for comparing online car ...
(Date:4/21/2015)... As a provider of holistic, result-driven ... their rehabilitation strategy, which involves various treatment modalities, produces ... an effort to offer hope and encouragement to those ... Best Drug Rehabilitation has featured a series of stories ... graduates of their recovery program. , One of ...
(Date:4/21/2015)... 21, 2015 Dr. Aaron Choroomi, dentist ... Group are now offering a valuable discount on restorative dental ... the promotional price of only $1695 for a limited time. ... patients for a limited time. , "There are times ... on the price," dental implants dentist , Dr. Choroomi, ...
(Date:4/21/2015)... Salt Lake City, Utah (PRWEB) April 21, 2015 ... insurance reimbursement for small businesses, announced today the publication ... , Recent health reform brought changes to the ... These changes caused some business owners to question what ... to use eBook helps small business owners determine which ...
Breaking Medicine News(10 mins):Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Collision Auto Insurance Covers Many Damages And Car Repairs 2Health News:Best Drug Rehabilitation Graduate Discusses Making Amends and Rebuilding Relationships 2Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2
... key to developing effective anti-skin cancer drugs, thanks to ... East Anglia (UEA). , The scientists have identified a ... the movement of the pigment cells that give the ... familiar greenish-brown of the adult frog. , It is ...
... 2008 Top 20 Best in KLAS Awards Also Ranks ... CTG HealthCare Solutions (CTGHS), a leading healthcare information ... CTG (Nasdaq: CTGX ), an international IT ... ranked second in the overall professional services firm rankings ...
... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) confirmed ... with the Securities and Exchange Commission from Amylin shareholder ... to nominate a slate of five directors to stand ... has not yet received the required notice with respect ...
... Diabetes and Digestive and Kidney Diseases has awarded a ... Graduate School of Public Health to coordinate the Hepatitis ... clinical and research centers in the U.S. and Canada ... , The network will include a multi-site treatment ...
... Two new studies found that exercise may be a ... knee arthroplasty or TKA) and knee osteoarthritis (OA). One ... knee replacement found that it enhanced clinical improvement almost ... study, the first to examine the relationship between four ...
... Jan. 29 Dr. Rachel Bennett, a noted infertility ... from Yorktown Heights to Mount Kisco, effective this month. ... range of infertility treatment options to women and men ... treating every patient with expert medical care and compassion. ...
Cached Medicine News:Health News:Skin color studies on tadpoles lead to cancer advance 2Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 2Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 3Health News:CTG HealthCare Solutions Ranked Second in Overall Professional Services Firm Category by KLAS Enterprises 4Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 2Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 3Health News:Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco 2
... Microdiscectomy System incorporates specially designed metal tubes ... area in a minimally invasive manner. These ... from 5.3 mm to 20.8 mm. The ... - one around the other - through ...
Fortitude as a unique complement to the spinal concepts family of products....
... Cougar is an Anterior Spinal Implant ... elasticity approximating that of cortical bone. The ... structural requirements of anterior column support, while ... load sharing design. Incorporates an anatomic design ...
Cervical Tissue Retractor 13 cm - 5 1/8, one blunt prong, 13 mm deep....
Medicine Products: